Saïdi Héla, Magri Giuliana, Carbonneil Cédric, Bouhlal Hicham, Hocini Hakim, Belec Laurent
Université Paris Descartes (Paris V), Unité INSERM U743 Immunologie Humaine, Equipe Immunité et Biothérapie Muqueuse, Centre de Recherches Biomédicales des Cordeliers, Paris, France.
AIDS Res Hum Retroviruses. 2009 May;25(5):497-509. doi: 10.1089/aid.2008.0156.
The in vitro model of HIV-1 transcytosis through a monolayer of HEC-1 cells is thought to mimic the mucosal crossing of the virus that may occur in vivo. We evaluated whether the stimulation of HEC-1 by HIV may modulate HIV infection of macrophages. Thus, the ability to capture, produce, and transfer R5 viruses to T cells, attract T cells, and finally produce cytokines/chemokines, was compared between untreated macrophages (M0) and macrophages differentiated in the presence of medium collected at the basolateral pole of HEC-1, which were unstimulated [M(BL)] or stimulated with either R5-HIV-1Ba-L [M(BL-R5)] or X4-HIV-1NDK [M(BL-X4)]. M(BL-X4)-secreted CCR5-interacting chemokines integrated and replicated HIV less efficiently than did M(BL) and M(BL-R5). M(BL-R5) and M(BL-X4) similarly transmitted HIV to activated T cells. Interestingly, mannose-binding receptors and heparan sulfate proteoglycans were variously involved in HIV adsorption, whereas DC-SIGN mostly mediated the HIV transfer. Conversely to M(BL) and M(BL-X4), M(BL-R5) did not secrete eotaxin, GRO, ITAC, lymphotactin, MIP-1, MIP-3, and RANTES, which was associated with a weak capacity to recruit CD4(+)CXCR4(+)CCR5(+) T cells. In particular, M(BL-R5) specifically released soluble factors enhancing HIV production by recruited T cells. These submucosal-conditioned macrophages differentially captured, produced, and transferred R5-HIV-1 to T cells, according to the tropism of the virus deposited at the apical pole of HEC-1. These observations challenge the question of the in vivo involvement of HIV-1 as a supraepithelial stimulus that likely modulates the susceptibility for HIV-1 of submucosal target cells in favor of its transmission.
人子宫内膜癌细胞系(HEC-1)单层细胞介导的HIV-1跨细胞转运体外模型被认为可模拟体内可能发生的病毒黏膜穿越过程。我们评估了HIV对HEC-1的刺激是否会调节巨噬细胞的HIV感染。因此,比较了未处理的巨噬细胞(M0)与在HEC-1基底外侧极收集的未刺激培养基[M(BL)]或用R5-HIV-1Ba-L [M(BL-R5)]或X4-HIV-1NDK [M(BL-X4)]刺激的培养基中分化的巨噬细胞捕获、产生并将R5病毒转移至T细胞、吸引T细胞以及最终产生细胞因子/趋化因子的能力。与M(BL)和M(BL-R5)相比,M(BL-X4)分泌的与CCR5相互作用的趋化因子整合和复制HIV的效率较低。M(BL-R5)和M(BL-X4)将HIV传递至活化T细胞的能力相似。有趣的是,甘露糖结合受体和硫酸乙酰肝素蛋白聚糖在HIV吸附中发挥不同作用,而树突状细胞特异性细胞间黏附分子-3抓取非整合素(DC-SIGN)主要介导HIV转移。与M(BL)和M(BL-X4)相反,M(BL-R5)不分泌嗜酸性粒细胞趋化因子、生长调节致癌基因蛋白(GRO)、干扰素诱导T细胞α趋化因子(ITAC)、淋巴细胞趋化因子、巨噬细胞炎性蛋白-1(MIP-1)、巨噬细胞炎性蛋白-3(MIP-3)和调节激活正常T细胞表达和分泌因子(RANTES),这与招募CD4(+)CXCR4(+)CCR5(+) T细胞的能力较弱有关。特别是,M(BL-R5)特异性释放可溶性因子,增强被招募T细胞的HIV产生。根据沉积在HEC-1顶端极的病毒嗜性,这些黏膜下条件巨噬细胞对R5-HIV-1的捕获、产生和转移至T细胞的能力存在差异。这些观察结果对HIV-1作为一种可能调节黏膜下靶细胞对HIV-1易感性以利于其传播的上皮上刺激在体内的作用这一问题提出了挑战。